NCT00375466View on ClinicalTrials.gov

Tranexamic Acid, Hemorrhage and Transfusions After Combined Aortic Valve Replacement and Coronary Artery Bypass Surgery.

NACompletedINTERVENTIONAL
Enrollment

63

Participants

Timeline

Start Date

September 30, 2006

Primary Completion Date

December 31, 2008

Study Completion Date

December 31, 2008

Conditions
Hemorrhage
Interventions
DRUG

Tranexamic acid

Tranexamic acid 10 mg/kg as a bolus dose followed by an infusion of 1 mg/kg/hour. Bolus given before start of surgery, infusion continued during surgery.

DRUG

placebo

0.9% sodium chloride 10 mg/kg, as a bolus injection before surgery followed by 1 mg/kg/h as an infusion during surgery

Trial Locations (1)

7006

St. Olav University Hospital, Trondheim

All Listed Sponsors
lead

St. Olavs Hospital

OTHER

NCT00375466 - Tranexamic Acid, Hemorrhage and Transfusions After Combined Aortic Valve Replacement and Coronary Artery Bypass Surgery. | Biotech Hunter | Biotech Hunter